Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|June 8, 2014
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentErnest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, et al.
Drug Safety|January 11, 2018
The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature ReviewMichael Nurmohamed, Ernest Choy, Sadiq Lula, et al.
RMD Open|November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritisMichael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Clinical Rheumatology|April 13, 2011
Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activityIzhar C van Eijk, Erik H Serné, Ben A C Dijkmans, et al.
Nutrients|December 11, 2019
Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic ReviewDaisy Vedder, Wendy Walrabenstein, Maaike Heslinga, et al.
Journal of Clinical Immunology|May 25, 2012
IgG4 production against adalimumab during long term treatment of RA patientsPauline A van Schouwenburg, Charlotte L Krieckaert, Michael Nurmohamed, et al.
The Lancet. Gastroenterology & Hepatology|April 3, 2018
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trialAnne S Strik, Wim van de Vrie, Joanne P J Bloemsaat-Minekus, et al.
Arthritis Care & Research|July 28, 2015
Effective Treatment for Rapid Improvement of Both Disease Activity and Self-Reported Physical Activity in Early Rheumatoid ArthritisNicole P C Konijn, Lilian H D van Tuyl, Maarten Boers, et al.
Arthritis Research & Therapy|March 5, 2024
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritisJianyang Liu, Helena Idborg, Marina Korotkova, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritisJonathan Aldridge, Anna-Carin Lundell, Kerstin Andersson, et al.
Pageof 3